From the dish to humans: A stem cell recipe for success.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 35108510.
- Also identified by DOI 10.1016/j.cmet.2022.01.002 and PMC identifier 9869932.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Islet transplantation has proven to be an effective treatment for type 1 diabetes (T1D) yet is hampered by the shortage of available tissue. Recently, two reports from a Viacyte multicenter clinical trial demonstrate the feasibility, safety, and potential efficacy of transplanting macro-encapsulated human stem cell-derived pancreatic endoderm cells into patients with T1D, highlighting the promise of a stem cell-based therapeutic approach.
Medical subject headings
- Diabetes Mellitus, Type 1
- Islets of Langerhans Transplantation